DE60311330D1 - Genetisches Verfahren zur Vorhersage des Glaukomarisikos - Google Patents

Genetisches Verfahren zur Vorhersage des Glaukomarisikos

Info

Publication number
DE60311330D1
DE60311330D1 DE60311330T DE60311330T DE60311330D1 DE 60311330 D1 DE60311330 D1 DE 60311330D1 DE 60311330 T DE60311330 T DE 60311330T DE 60311330 T DE60311330 T DE 60311330T DE 60311330 D1 DE60311330 D1 DE 60311330D1
Authority
DE
Germany
Prior art keywords
prediction
genetic method
glaucoma
glaucoma risk
risk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60311330T
Other languages
English (en)
Other versions
DE60311330T2 (de
Inventor
Yasuhiro Kouchi
Akinori Masago
Takayuki Takahata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sysmex Corp
Original Assignee
Sysmex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sysmex Corp filed Critical Sysmex Corp
Application granted granted Critical
Publication of DE60311330D1 publication Critical patent/DE60311330D1/de
Publication of DE60311330T2 publication Critical patent/DE60311330T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
DE60311330T 2002-08-02 2003-07-29 Genetisches Verfahren zur Vorhersage des Glaukomarisikos Expired - Fee Related DE60311330T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002226612 2002-08-02
JP2002226612 2002-08-02

Publications (2)

Publication Number Publication Date
DE60311330D1 true DE60311330D1 (de) 2007-03-08
DE60311330T2 DE60311330T2 (de) 2007-11-22

Family

ID=30437717

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60304518T Expired - Fee Related DE60304518T2 (de) 2002-08-02 2003-07-29 Genetisches Verfahren zur Vorhersage des Glaukomarisikos
DE60311330T Expired - Fee Related DE60311330T2 (de) 2002-08-02 2003-07-29 Genetisches Verfahren zur Vorhersage des Glaukomarisikos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE60304518T Expired - Fee Related DE60304518T2 (de) 2002-08-02 2003-07-29 Genetisches Verfahren zur Vorhersage des Glaukomarisikos

Country Status (4)

Country Link
US (1) US20040091914A1 (de)
EP (2) EP1647603B1 (de)
AT (2) ATE323181T1 (de)
DE (2) DE60304518T2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG182159A1 (en) * 2007-06-13 2012-07-30 Decode Genetics Ehf Genetic variants on chr 15q24 as markers for use in diagnosis, prognosis and treatment of exfoliation syndrome and glaucoma
CN109453380A (zh) * 2018-09-29 2019-03-12 浙江大学 optineurin蛋白在制备诊断和治疗急性肝损伤产品中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0966537B1 (de) * 1997-03-11 2009-01-07 Stichting Dienst Landbouwkundig Onderzoek Fasciola hepatica impfstoffe
EP1293569A3 (de) * 2001-09-14 2004-03-31 Research Association for Biotechnology Vollständige cDNA-Sequenzen
WO2003056037A1 (en) * 2001-12-24 2003-07-10 University Of Connecticut Optineurin and glaucoma

Also Published As

Publication number Publication date
EP1388590B1 (de) 2006-04-12
EP1647603A2 (de) 2006-04-19
EP1388590A2 (de) 2004-02-11
DE60311330T2 (de) 2007-11-22
DE60304518D1 (de) 2006-05-24
EP1388590A3 (de) 2004-05-06
DE60304518T2 (de) 2006-11-23
ATE323181T1 (de) 2006-04-15
US20040091914A1 (en) 2004-05-13
ATE351926T1 (de) 2007-02-15
EP1647603A3 (de) 2006-05-03
EP1647603B1 (de) 2007-01-17

Similar Documents

Publication Publication Date Title
DE602004018541D1 (de) System und verfahren zur optimierung des eisenbahnbetriebs auf mehreren ebenen
ATE353322T1 (de) Verfahren zur herstellung von 2- (chinoxalin-5- ylsulfonylamino) -benzamid-verbindungen
ATE550438T1 (de) Verfahren zur quantitativen bestimmung der methylierungsdichte in einem dna-locus
IS6316A (is) Aðferð til erfðafræðilegra greininga
DE60336238D1 (de) Verfahren zur herstellung von n-halbleiterdiamant und halbleiterdiamant
IL176674A0 (en) Fc region variants
DE50209307D1 (de) Vorrichtung zur fussbekleidung
ATE540129T1 (de) Target zur therapie kognitiver behinderungen
ATE396180T1 (de) Verfahren zur herstellung von 2,6-diamino-4,5,6,7-tetrahydrobenzothiazol
ATE471924T1 (de) 3-alkyl-5,5',6,6',7,7',8,8'-octahydro-2,2'- binaphthole und 3,3'-dialkyl-5,5',6,6',7,7',8,8'- octahydro-2,2'-binaphthole, sowie verfahren zur ihrer herstellung
ATA11912002A (de) Verfahren zur herstellung von fälschungssicheren identifikationsmerkmalen
DK1458888T3 (da) Fremgangsmåder til behandling af psykose og skizofreni baseret på polymorfier i CNTF-genet
DE60333291D1 (de) Verfahren zur herstellung von flachglas
DE502004004773D1 (de) Verfahren zur ansteuerung von personenschutzmitteln
ATE477342T1 (de) Verfahren zur herstellung von hartmetallgranulat
DE602004026253D1 (de) Verfahren zur Herstellung von Stahlbrammen mit ultra-geringem Kohlenstoffgehalt
CY1110138T1 (el) Προσδιορισμος υψηλης διεκπεραιωτικοτητας της δραστικοτητας lp-pla2
ATE455778T1 (de) Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat
DE60331111D1 (de) Verfahren zur Herstellung von martensitaushärtendem Stahl
DE60304518D1 (de) Genetisches Verfahren zur Vorhersage des Glaukomarisikos
DE60323607D1 (de) Verfahren zur rekombination genetischer elemente
ATE416756T1 (de) Methoden zur verwendung von lamellaren körpern für therapeutische zwecke
DE60324272D1 (de) Verfahren zum kühlen von stahlblech und verfahren zur herstellung von stahlblech
ATE284911T1 (de) Verfahren zur herstellung von polyetherpolyolen
ATE399868T1 (de) Optimierte nukleotidsequenzen die für sgp130 kodieren

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: KOUCHI, YASUHIRO, KOBE, HYOGO, JP

Inventor name: MASAGO, AKINORI, KOBE, HYOGO, JP

Inventor name: TAKAHATA, TAKAYUKI, KOBE, HYOGO, JP

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee